MMPI
CALA

Morgenthaler Management Partners IX’s Calithera Biosciences, Inc CALA Stock Holding History

Morgenthaler Management Partners IX’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$7.03M Hold
108,096
– – 100% 1
2016
Q2 		$8.28M Hold
108,096
– – 100% 1
2016
Q1 		$12.3M Hold
108,096
– – 17.9% 3
2015
Q4 		$16.6M Buy
+108,096
New +$16.2M 18.02% 3

Other funds holding CALA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Morgenthaler Management Partners IX's CALA Position: Q3 2016 in Review

Morgenthaler Management Partners IX held its Calithera Biosciences, Inc (CALA) position steady in Q3 2016 at 108,096 shares worth $7.03M. The position accounts for 100% of the portfolio, ranked #1.

Morgenthaler Management Partners IX first reported a position in CALA in Q4 2015 and has held it in 4 quarters since. The position peaked at $16.6M in Q4 2015. 40 funds tracked by Wall St. Rank hold CALA as of Q3 2016.

  • Morgenthaler Management Partners IX held 108,096 shares of Calithera Biosciences, Inc worth $7.03M as of Q3 2016.
  • Morgenthaler Management Partners IX left its Calithera Biosciences, Inc share count unchanged in Q3 2016.
  • Calithera Biosciences, Inc made up 100% of Morgenthaler Management Partners IX's portfolio in Q3 2016, its #1 holding.
  • Morgenthaler Management Partners IX first reported a position in Calithera Biosciences, Inc in Q4 2015 and has held it in 4 quarters since.
  • Morgenthaler Management Partners IX's Calithera Biosciences, Inc position peaked at $16.6M in Q4 2015.
  • 40 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2016.

Based on Morgenthaler Management Partners IX's 13F filing for Q3 2016, filed 8 Nov 2016.